Merck & Co., Inc. (MRK)
146.95
-0.23
(-0.16%)
USD |
NYSE |
Nov 12, 16:00
147.12
+0.17
(+0.12%)
Pre-Market: 06:58
Merck Gross Profit Margin (Quarterly) : 71.65% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 71.65% |
| June 30, 2026 | 71.51% |
| March 31, 2026 | 71.98% |
| December 31, 2025 | 70.49% |
| September 30, 2025 | 75.59% |
| June 30, 2025 | 75.65% |
| March 31, 2025 | 75.13% |
| December 31, 2024 | 76.93% |
| September 30, 2024 | 73.43% |
| June 30, 2024 | 73.43% |
| March 31, 2024 | 75.11% |
| December 31, 2023 | 69.77% |
| September 30, 2023 | 70.74% |
| June 30, 2023 | 70.67% |
| March 31, 2023 | 70.21% |
| December 31, 2022 | 69.22% |
| September 30, 2022 | 74.50% |
| June 30, 2022 | 71.97% |
| March 31, 2022 | 66.60% |
| December 31, 2021 | 72.55% |
| September 30, 2021 | 74.06% |
| June 30, 2021 | 72.97% |
| March 31, 2021 | 69.84% |
| December 31, 2020 | 54.29% |
| September 30, 2020 | 72.70% |
| Date | Value |
|---|---|
| June 30, 2020 | 70.78% |
| March 31, 2020 | 72.98% |
| December 31, 2019 | 69.70% |
| September 30, 2019 | 68.11% |
| June 30, 2019 | 71.44% |
| March 31, 2019 | 72.01% |
| December 31, 2018 | 70.17% |
| September 30, 2018 | 66.51% |
| June 30, 2018 | 66.99% |
| March 31, 2018 | 68.65% |
| December 31, 2017 | 67.80% |
| September 30, 2017 | 68.17% |
| June 30, 2017 | 68.79% |
| March 31, 2017 | 69.21% |
| December 31, 2016 | 67.18% |
| September 30, 2016 | 67.85% |
| June 30, 2016 | 65.06% |
| March 31, 2016 | 64.30% |
| December 31, 2015 | 62.71% |
| September 30, 2015 | 62.73% |
| June 30, 2015 | 62.00% |
| March 31, 2015 | 62.71% |
| December 31, 2014 | 60.71% |
| September 30, 2014 | 75.06% |
| June 30, 2014 | 62.84% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 68.11% |
| Eli Lilly & Co. | 83.88% |
| Pfizer Inc. | 68.17% |
| Bristol Myers Squibb Co. | 64.79% |
| Abbott Laboratories | 50.36% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 5.16% |
| Return on Assets | 1.86% |
| Return on Invested Capital | 2.52% |
| Profit Margin (Quarterly) | 27.96% |
| Operating Margin (Quarterly) | 40.72% |
| Return on Net Operating Assets | 2.73% |